Nanotherapeutics received expanded 510(k) marketing clearance from the U.S. Food and Drug Administration for use of NanoFUSE DBM in spinal fusion.
↧
Nanotherapeutics received expanded 510(k) marketing clearance from the U.S. Food and Drug Administration for use of NanoFUSE DBM in spinal fusion.